Addressing Gaps for Women With HIV Involved in the Criminal Justice System

Jaimie P. Meyer, MD, from the Yale School of Medicine, discusses her work on identifying opportunities to reduce risk for HIV transmission, particularly in women ...

Treating and Preventing HIV With Generic Drugs

Generic antiretroviral agents have had a dramatic effect on outcomes in developing nations, and their availability in developed countries is rapidly expanding as more brand-name ...

Treating Major Depressive Disorder Improves Outcomes in HIV

Mental health problems are 1 of the most important reasons for failing to engage in long-term control of HIV.

Improving Adherence to ART in HIV

The rapidly developing landscape of antiretroviral therapy adherence monitoring has great potential for clinical application, but cost-effectiveness and feasibility studies are needed to define the ...

Preventing HIV, STIs Through School-Based Programs

Although a positive impact on behavior change has been reported following the implementation of curriculum-based programs, there is a lack of clear evidence that school-based ...

PrEP Crucial for People Involved in Criminal Justice Systems

Important strategies to consider for people involved in the criminal justice systems include linkage to antiretroviral therapy for those who are HIV positive and linkage ...

Pausing ART: Safety and Ethical Considerations

Dr Gianella Weibel talks with Dr Li and Dr Dubé, investigators of a new study from the AIDS Clinical Trials Group, which uses an intensively ...
HIV/AIDS

Latest News

Tolerability of Switching to Long-acting Cabotegravir Plus Rilpivirine From Current HIV-1 Regimen

Tolerability of Switching to Long-acting Cabotegravir Plus Rilpivirine From Current HIV-1 Regimen

The ATLAS study enrolled 570 patients infected with HIV-1; participants were randomized to either the experimental or active comparator arms.

FDA Updates Labeling for Several HIV Medications to Include Interaction Data With DOACs

FDA Updates Labeling for Several HIV Medications to Include Interaction Data With DOACs

The FDA has approved labeling updates for Genvoya, Stribild and Tybost to include new drug-drug interaction data.

International Antiviral Society-USA Updates Recommendations for HIV Treatment and Prevention

International Antiviral Society-USA Updates Recommendations for HIV Treatment and Prevention

The International Antiviral Society-USA Panel has updated its recommendations for the management and prevention of HIV infection, to reflect the most current data on new treatment regimens and strategies.

Previous Missed Appointments Predict Likelihood of Trend in Patients With HIV

Previous Missed Appointments Predict Likelihood of Trend in Patients With HIV

In a large, geographically diverse sample of patients engaged in routine HIV primary care, past HIV appointment attendance emerged as the most powerful predictor of future attendance.

Low HIV, Syphilis Screening Rates for Adolescents With Pelvic Inflammatory Disease

Low HIV, Syphilis Screening Rates for Adolescents With Pelvic Inflammatory Disease

New research found low and highly variable rates of HIV and syphilis screening among adolescents with pelvic inflammatory disease.

Low Rates of Syphilis Testing in High-Risk Men Who Are HIV Positive

Low Rates of Syphilis Testing in High-Risk Men Who Are HIV Positive

Close to one-third of sexually active HIV-positive men who have sex with men (MSM) have not received syphilis screening in the past 12 months.

Addressing Motivations That May Drive PrEP Appeal in MSM

Addressing Motivations That May Drive PrEP Appeal in MSM

A new theoretical model of understanding (PrEP) use intention in MSM highlights the complexity of decision-making about PrEP in MSM while providing insights into strategies for effective intervention.

Protease Inhibitors May Worsen Outcomes for Patients With HIV, Heart Failure

Protease Inhibitors May Worsen Outcomes for Patients With HIV, Heart Failure

Ritonavir-boosted protease inhibitor therapy is associated with worse outcomes, including death, in patients with HIV and heart failure.

Effects of Alcohol on Frontal White Matter in HIV-Infected Individuals

Effects of Alcohol on Frontal White Matter in HIV-Infected Individuals

Alcohol use may be associated with microstructural compromise to frontal white matter in patients infected with HIV who do not have dementia and are undergoing antiretroviral therapy.

Guidelines for ART Updated for Those With or at Risk for HIV

Guidelines for ART Updated for Those With or at Risk for HIV

ART recommended for almost all HIV-infected; should be initiated as soon as possible post diagnosis.

Feature Article

Insight Into the HIV Self-Testing Debate

Insight Into the HIV Self-Testing Debate

Although the CDC recommends routine HIV screening for all people age 13-64 years, numerous barriers to HIV testing in healthcare settings have been identified, including lack of access and fear of stigma and discrimination.

Telling Children Their HIV Status: Interview With Dr Elizabeth Lowenthal

Telling Children Their HIV Status: Interview With Dr Elizabeth Lowenthal

Infectious Disease Advisor speaks with Elizabeth D. Lowenthal, MD, about the challenges associated with revealing HIV seropositive status to children.

Psychosocial Interventions in HIV: How Best to Support HIV-Positive Patients

Psychosocial Interventions in HIV: How Best to Support HIV-Positive Patients

Mental health professionals supporting patients living with HIV need to make space for their patients to process the emotional effect of their diagnosis, but not to make assumptions about what it means to them.

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Transcutaneous vagus nerve stimulation could provide a safe alternative treatment in HIV-depression by targeting both depression and other comorbidities that can burden people living with HIV.

How HIV Affects Cervical Cancer Risk and Outcomes

How HIV Affects Cervical Cancer Risk and Outcomes

Women with HIV have an increased risk for persistent HPV infection, which frequently progresses to cervical cancer, and they should be warned of their increased risk for HPV and cervical cancer and, when appropriate, advised to undergo HPV vaccination.

Linkage to HIV Care: To Give or Not to Give Financial Incentives?

Linkage to HIV Care: To Give or Not to Give Financial Incentives?

Use of incentives makes the most sense with disadvantaged populations including homeless, drug users, and people in developing countries.

Role of the Microbiome on HIV Infection, Prevention, and Treatment

Role of the Microbiome on HIV Infection, Prevention, and Treatment

The interactions between HIV, ART, human sexual behavior, and the gut microbiome are complex and sorting out these interactions will be important to design future interventions.

Adolescents at Risk for HIV Should Be Offered PrEP

Adolescents at Risk for HIV Should Be Offered PrEP

Experts discuss new findings supporting the need for PrEP in adolescents and discuss the continued debate surrounding parental consent and other relevant issues.

Assessing the Risk Factors of Neurocognitive Decline in HIV+ Individuals

Assessing the Risk Factors of Neurocognitive Decline in HIV+ Individuals

The incidence of neurocognitive impairment is high in HIV-infected population, despite the introduction of combination antiretroviral therapy (CART).

Why Patients Discontinue ART— and What You Can Do to Stop It

Why Patients Discontinue ART— and What You Can Do to Stop It

Learn more about when stopping antiretroviral therapy (ART) may be necessary, why patients discontinue ART, predicting viral suppression, and predicting and encouraging adherence.

Slideshows

SIGN UP FOR FREE E-NEWSLETTERS